4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-022538
EVP, Head of North America sold 1,638 shares at an average $50.80 ($83,207)
- EVP, Head of North America acquired 5,469 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lee Jennifer Kayden · EVP, Head of North America
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-09 | Exercise or conversion : show line 1 in the form | +3,438 | 6,459 | D | ||
| 2024-02-11 | Exercise or conversion : show line 2 in the form | +2,031 | 8,490 | D | ||
| 2024-02-12 | Sale : show line 3 in the form | −1,023 | $51.38 | $52,562 | 7,467 | D |
| 2024-02-13 | Sale : show line 4 in the form | −615 | $49.83 | $30,645 | 6,852 | D |
| Open-market sales · 1,638 sh · avg $50.80 · $83,207 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-09 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −3,438 | 6,874 | D |
| 2024-02-11 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −2,031 | 2,031 | D |
Loading xslF345X05/tm246165-3_4seq1.xml…